Identification of Nω-carboxymethylarginine, as a new advanced glycation endproduct in serum proteins of diabetic patients

A new AGE, Nω-carboxymethylarginine (CMA), was found in acid-soluble skin collagen of a newborn bovine prepared in vitro glycation with 1 M glucose incubation at 37 °C for about 30 days. CMA production was increased with incubation time in parallel, and after 30-day incubation, the yield was 100 tim...

Full description

Saved in:
Bibliographic Details
Published in:International Congress series 2002-11, Vol.1245, p.295-301
Main Authors: Odani, Hiroko, Iijima, Katsumasa, Nakata, Minoru, Miyata, Satoshi, Yasuda, Yoshinari, Irie, Shinkichi, Maeda, Kenji, Fujimoto, Daisaburou
Format: Article
Language:English
Subjects:
Carboxymethylarginine
Collagen
Diabetes
Enzymatic hydrolysis
ESI/LC/MS
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A new AGE, Nω-carboxymethylarginine (CMA), was found in acid-soluble skin collagen of a newborn bovine prepared in vitro glycation with 1 M glucose incubation at 37 °C for about 30 days. CMA production was increased with incubation time in parallel, and after 30-day incubation, the yield was 100 times higher than that of pentosidine. This result suggested the importance of CMA as a major AGE in collagen. We have detected and measured the CMA level in human serum proteins by electrospray ionization/liquid chromatography/mass spectrometry (ESI/LC/MS), using CMA standard concentration curve. In this study, we first show the existence of CMA in vivo, and its serum level is significantly elevated in diabetic serum proteins, compared to age-matched control serum proteins. These results provide the possibility of CMA as a new diagnostic marker of glycation in diabetes.
ISSN:0531-5131
1873-6157
DOI:10.1016/S0531-5131(02)01032-4